# Herc Holdings Inc: financial statements, quarterly

HRI · NYSE · CIK 1364479 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hri.md) · [Financials](/companies/hri/financials.md) · [Filings](/companies/hri/filings.md) · [Insiders](/companies/hri/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hri/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [(1,850) d](/filings/0001364479-26-000050.md) | [804](/filings/0001364479-25-000027.md) | [136](/filings/0001364479-25-000040.md) | [157](/filings/0001364479-25-000056.md) | [169 d](/filings/0001364479-26-000050.md) | [170](/filings/0001364479-26-000085.md) | [192](/filings/0001364479-26-000109.md) | [259](/filings/0001628280-26-067396.md) | [241 d](/filings/0001364479-26-000050.md) | [220](/filings/0001364479-26-000085.md) | [204](/filings/0001364479-26-000109.md) | [193](/filings/0001628280-26-067396.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [108 d](/filings/0001364479-26-000050.md) | [112](/filings/0001364479-25-000027.md) | [117](/filings/0001364479-25-000040.md) | [120](/filings/0001364479-25-000056.md) | [120 d](/filings/0001364479-26-000050.md) | [118](/filings/0001364479-26-000085.md) | [127](/filings/0001364479-26-000109.md) | [166](/filings/0001628280-26-067396.md) | [153 d](/filings/0001364479-26-000050.md) | [146](/filings/0001364479-26-000085.md) | [155](/filings/0001364479-26-000109.md) | [178](/filings/0001628280-26-067396.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [32.0 d](/filings/0001364479-26-000050.md) | [16.0](/filings/0001364479-25-000027.md) | [23.0](/filings/0001364479-25-000040.md) | [38.0](/filings/0001364479-25-000056.md) | [3.0 d](/filings/0001364479-26-000050.md) | [10.0](/filings/0001364479-26-000085.md) | [(11.0)](/filings/0001364479-26-000109.md) | [8.0](/filings/0001628280-26-067396.md) | [(7.0) d](/filings/0001364479-26-000050.md) | [1.0](/filings/0001364479-26-000085.md) | [5.0](/filings/0001364479-26-000109.md) | [16.0](/filings/0001628280-26-067396.md) |
| Net income | $m | [91.0 d](/filings/0001364479-26-000050.md) | [65.0](/filings/0001364479-25-000056.md) | [70.0](/filings/0001364479-25-000056.md) | [122](/filings/0001364479-25-000056.md) | [(46.0) d](/filings/0001364479-26-000050.md) | [(18.0)](/filings/0001628280-26-067396.md) | [(35.0)](/filings/0001628280-26-067396.md) | [30.0](/filings/0001628280-26-067396.md) | [24.0 d](/filings/0001364479-26-000050.md) | [(24.0)](/filings/0001628280-26-067396.md) | [19.0](/filings/0001628280-26-067396.md) | [104](/filings/0001628280-26-067396.md) |
| Diluted EPS | $ per share | not reported | [2.29](/filings/0001364479-25-000027.md) | [2.46](/filings/0001364479-25-000040.md) | [4.28](/filings/0001364479-25-000056.md) | not reported | [(0.63)](/filings/0001364479-26-000085.md) | [(1.17)](/filings/0001364479-26-000109.md) | [0.90](/filings/0001628280-26-067396.md) | not reported | [(0.72)](/filings/0001364479-26-000085.md) | [0.57](/filings/0001364479-26-000109.md) | [3.10](/filings/0001628280-26-067396.md) |
| Basic EPS | $ per share | not reported | [2.30](/filings/0001364479-25-000027.md) | [2.46](/filings/0001364479-25-000040.md) | [4.30](/filings/0001364479-25-000056.md) | not reported | [(0.63)](/filings/0001364479-26-000085.md) | [(1.17)](/filings/0001364479-26-000109.md) | [0.90](/filings/0001628280-26-067396.md) | not reported | [(0.72)](/filings/0001364479-26-000085.md) | [0.57](/filings/0001364479-26-000109.md) | [3.11](/filings/0001628280-26-067396.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001364479-25-000007.md) | [0.1](/filings/0001364479-24-000026.md) | [0.1](/filings/0001364479-24-000042.md) | [0.1](/filings/0001364479-24-000058.md) | [0.1](/filings/0001364479-26-000050.md) | [0.0](/filings/0001364479-25-000027.md) | [0.1](/filings/0001364479-25-000040.md) | [0.1](/filings/0001364479-25-000056.md) | [0.1](/filings/0001628280-26-067396.md) | [0.0](/filings/0001364479-26-000085.md) | [0.0](/filings/0001364479-26-000109.md) | [0.1](/filings/0001628280-26-067396.md) |
| Current assets | $bn | [0.7](/filings/0001364479-25-000007.md) | [0.7](/filings/0001364479-24-000026.md) | [0.7](/filings/0001364479-24-000042.md) | [0.9](/filings/0001364479-24-000058.md) | [0.8](/filings/0001364479-26-000050.md) | [0.7](/filings/0001364479-25-000027.md) | [0.9](/filings/0001364479-25-000040.md) | [1.0](/filings/0001364479-25-000056.md) | [1.0](/filings/0001628280-26-067396.md) | [0.9](/filings/0001364479-26-000085.md) | [1.0](/filings/0001364479-26-000109.md) | [1.1](/filings/0001628280-26-067396.md) |
| Total assets | $bn | [7.1](/filings/0001364479-25-000007.md) | [7.2](/filings/0001364479-24-000026.md) | [7.6](/filings/0001364479-24-000042.md) | [8.2](/filings/0001364479-24-000058.md) | [7.9](/filings/0001364479-26-000050.md) | [7.7](/filings/0001364479-25-000027.md) | [14.0](/filings/0001364479-25-000040.md) | [13.9](/filings/0001364479-25-000056.md) | [13.8](/filings/0001628280-26-067396.md) | [13.6](/filings/0001364479-26-000085.md) | [13.7](/filings/0001364479-26-000109.md) | [14.1](/filings/0001628280-26-067396.md) |
| Current liabilities | $bn | [0.5](/filings/0001364479-25-000007.md) | [0.5](/filings/0001364479-24-000026.md) | [0.6](/filings/0001364479-24-000042.md) | [0.7](/filings/0001364479-24-000058.md) | [0.6](/filings/0001364479-26-000050.md) | [0.5](/filings/0001364479-25-000027.md) | [0.8](/filings/0001364479-25-000040.md) | [0.8](/filings/0001364479-25-000056.md) | [0.7](/filings/0001628280-26-067396.md) | [0.6](/filings/0001364479-26-000085.md) | [0.9](/filings/0001364479-26-000109.md) | [1.0](/filings/0001628280-26-067396.md) |
| Total liabilities | $bn | [5.8](/filings/0001364479-25-000007.md) | [5.9](/filings/0001364479-24-000026.md) | [6.2](/filings/0001364479-24-000042.md) | [6.7](/filings/0001364479-24-000058.md) | [6.5](/filings/0001364479-26-000050.md) | [6.3](/filings/0001364479-25-000027.md) | [12.1](/filings/0001364479-25-000040.md) | [12.0](/filings/0001364479-25-000056.md) | [11.8](/filings/0001628280-26-067396.md) | [11.7](/filings/0001364479-26-000085.md) | [11.8](/filings/0001364479-26-000109.md) | [12.1](/filings/0001628280-26-067396.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.3](/filings/0001364479-26-000050.md) | [1.3](/filings/0001364479-25-000056.md) | [1.4](/filings/0001364479-25-000056.md) | [1.5](/filings/0001364479-25-000056.md) | [1.4](/filings/0001628280-26-067396.md) | [1.4](/filings/0001628280-26-067396.md) | [1.9](/filings/0001628280-26-067396.md) | [1.9](/filings/0001628280-26-067396.md) | [1.9](/filings/0001628280-26-067396.md) | [1.9](/filings/0001628280-26-067396.md) | [1.9](/filings/0001628280-26-067396.md) | [2.0](/filings/0001628280-26-067396.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [290 d](/filings/0001364479-26-000050.md) | [240](/filings/0001364479-25-000027.md) | [318 d](/filings/0001364479-25-000040.md) | [336 d](/filings/0001364479-25-000056.md) | [331 d](/filings/0001364479-26-000050.md) | [171](/filings/0001364479-26-000085.md) | [241 d](/filings/0001364479-26-000109.md) | [358 d](/filings/0001628280-26-067396.md) | [315 d](/filings/0001364479-26-000050.md) | [277](/filings/0001364479-26-000085.md) | [314 d](/filings/0001364479-26-000109.md) | [360 d](/filings/0001628280-26-067396.md) |
| Capital expenditure | $m | [37.0 d](/filings/0001364479-26-000050.md) | [30.0](/filings/0001364479-25-000027.md) | [41.0 d](/filings/0001364479-25-000040.md) | [56.0 d](/filings/0001364479-25-000056.md) | [34.0 d](/filings/0001364479-26-000050.md) | [33.0](/filings/0001364479-26-000085.md) | [47.0 d](/filings/0001364479-26-000109.md) | [43.0 d](/filings/0001628280-26-067396.md) | [34.0 d](/filings/0001364479-26-000050.md) | [41.0](/filings/0001364479-26-000085.md) | [41.0 d](/filings/0001364479-26-000109.md) | [25.0 d](/filings/0001628280-26-067396.md) |
| Dividends paid | $m | [17.0 d](/filings/0001364479-26-000050.md) | [20.0](/filings/0001364479-25-000027.md) | [19.0 d](/filings/0001364479-25-000040.md) | [19.0 d](/filings/0001364479-25-000056.md) | [19.0 d](/filings/0001364479-26-000050.md) | [21.0](/filings/0001364479-26-000085.md) | [20.0 d](/filings/0001364479-26-000109.md) | [23.0 d](/filings/0001628280-26-067396.md) | [23.0 d](/filings/0001364479-26-000050.md) | [24.0](/filings/0001364479-26-000085.md) | [23.0 d](/filings/0001364479-26-000109.md) | [24.0 d](/filings/0001628280-26-067396.md) |
| Share repurchases | $m | [13.0 d](/filings/0001364479-26-000050.md) | [0.0](/filings/0001364479-24-000026.md) | [0.0 d](/filings/0001364479-24-000042.md) | [0.0 d](/filings/0001364479-24-000058.md) | [0.0 d](/filings/0001364479-26-000050.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.4](/filings/0001364479-24-000026.md) | [28.6](/filings/0001364479-24-000042.md) | [28.5](/filings/0001364479-24-000058.md) | [28.4](/filings/0001364479-25-000027.md) | [28.5](/filings/0001364479-25-000040.md) | [28.5](/filings/0001364479-25-000056.md) | [28.5](/filings/0001364479-26-000085.md) | [30.0](/filings/0001364479-26-000109.md) | [33.3](/filings/0001628280-26-067396.md) | [33.3](/filings/0001364479-26-000085.md) | [33.5](/filings/0001364479-26-000109.md) | [33.5](/filings/0001628280-26-067396.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,463,396 at 2026-10-23, from the cover of the [10-Q filed 2026-10-27](/filings/0001628280-26-067396.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 13:15 ET. No prices; not investment advice.